Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions.
St Peter WL, Bzowyckyj AS, Anderson-Haag T, Awdishu L, Blackman M, Bland A, Chan E, Chmielewski C, Delgado C, Eyler R, Foster C, Hudson J, Kane-Gill SL, Kliethermes MA, Le T, Madabushi R, Martin B, Miller WG, Neumiller JJ, Philbrick AM, Roberts G, Schandorf V, Webb AJ, Wu D, Nolin TD; Written on behalf of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions. St Peter WL, et al. Among authors: madabushi r. Am J Health Syst Pharm. 2024 Nov 18:zxae317. doi: 10.1093/ajhp/zxae317. Online ahead of print. Am J Health Syst Pharm. 2024. PMID: 39552516
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations.
Donnelly M, Fang L, Madabushi R, Zhu H, Luke M, Canterbury C, Lerman B, Kaur P, Patel D, Sun W, Schuirmann D, Dinsmore S, Mehta M, Zhao L. Donnelly M, et al. Among authors: madabushi r. Clin Pharmacol Ther. 2024 Nov 11. doi: 10.1002/cpt.3460. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 39529254 Review.
Model-Informed Drug Development-Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non-Radiographic Axial Spondyloarthritis.
Pisal DS, Li Y, Golding A, Nair R, Nikolov NP, Madabushi R, Zhu H, Doddapaneni S, Sahajwalla C, Bi Y, Chen J. Pisal DS, et al. Among authors: madabushi r. Clin Pharmacol Ther. 2024 Oct 16. doi: 10.1002/cpt.3464. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 39411974
79 results